Bridgeway Capital Management, LLC Ocular Therapeutix, Inc Transaction History

Bridgeway Capital Management, LLC

  • $4.44 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019
SELL
$2.46 - $4.52 $426,072 - $782,863
-173,200 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$3.51 - $4.77 $245,348 - $333,422
69,900 Added 67.67%
173,200 $688,000
Q3 2017

Nov 14, 2017
BUY
$5.28 - $6.88 $545,424 - $710,704
103,300
103,300 $638,000

Others Institutions Holding OCUL

# of Institutions
172
Shares Held
138M
Call Options Held
150K
Put Options Held
225K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $761M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email